Correlation Between 23Andme Holding and Regulus Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Regulus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Regulus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Regulus Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Regulus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Regulus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Regulus Therapeutics.
Diversification Opportunities for 23Andme Holding and Regulus Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 23Andme and Regulus is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Regulus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regulus Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Regulus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regulus Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Regulus Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Regulus Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Regulus Therapeutics. In addition to that, 23Andme Holding is 2.36 times more volatile than Regulus Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Regulus Therapeutics is currently generating about 0.13 per unit of volatility. If you would invest 149.00 in Regulus Therapeutics on September 4, 2024 and sell it today you would earn a total of 14.00 from holding Regulus Therapeutics or generate 9.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Regulus Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Regulus Therapeutics |
23Andme Holding and Regulus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Regulus Therapeutics
The main advantage of trading using opposite 23Andme Holding and Regulus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Regulus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regulus Therapeutics will offset losses from the drop in Regulus Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Regulus Therapeutics vs. Tenax Therapeutics | Regulus Therapeutics vs. Verastem | Regulus Therapeutics vs. Pulmatrix | Regulus Therapeutics vs. Cellectar Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |